Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junwei Sun

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
National Science Review|October 3, 2025
3D-printed stretchable modular integrated microsystems toward sweat monitoring powered by wireless charging sodium-ion micro-batteriesZhihao Ren, Xiaoyu Shi, Endian Yang, et al.
Cellular and Molecular Gastroenterology and Hepatology|September 12, 2022
HBV X Protein Induces Degradation of UBXN7, a Novel Negative Regulator of NF-κB Signaling, to Promote HBV ReplicationSen Yuan, Jiaqi Xu, Min Wang, et al.
British Journal of Pharmacology|June 28, 2022
Maresin 1 intervention reverses experimental pulmonary arterial hypertension in miceHui Li, Xinyu Li, Yu Hao, et al.
Molecular Therapy. Nucleic Acids|July 7, 2022
Upregulation of miR-520c-3p via hepatitis B virus drives hepatocellular migration and invasion by the PTEN/AKT/NF-κB axisYang Liu, Jingwen Wang, Jianwen Chen, et al.
Plant Communications|May 1, 2026
Decoupling the 'Attract-and-Kill' Strategy: Independent Functions for Zoospore Attraction and ROS-Executed Killing Synergize in Disease-Suppressive IntercroppingYixiang Liu, Jiaqing Wu, Yuxin Yang, et al.
Science Translational Medicine|February 11, 2012
AAV2 gene therapy readministration in three adults with congenital blindnessJean Bennett, Manzar Ashtari, Jennifer Wellman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 3, 2009
Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administrationFrancesca Simonelli, Albert M Maguire, Francesco Testa, et al.
Lancet (London, England)|July 5, 2016
Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trialJean Bennett, Jennifer Wellman, Kathleen A Marshall, et al.
Nature|January 14, 2026
Direct observation of the Migdal effect induced by neutron bombardmentDifan Yi, Qian Liu, Shi Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 2, 2025
Recovery of cone-mediated vision in Lebercilin associated retinal ciliopathy after gene therapy: One-year results of a phase I/II trialTomas S Aleman, Katherine E Uyhazi, Alejandro J Roman, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
National Science Review|October 3, 2025
3D-printed stretchable modular integrated microsystems toward sweat monitoring powered by wireless charging sodium-ion micro-batteriesZhihao Ren, Xiaoyu Shi, Endian Yang, et al.
Cellular and Molecular Gastroenterology and Hepatology|September 12, 2022
HBV X Protein Induces Degradation of UBXN7, a Novel Negative Regulator of NF-κB Signaling, to Promote HBV ReplicationSen Yuan, Jiaqi Xu, Min Wang, et al.
British Journal of Pharmacology|June 28, 2022
Maresin 1 intervention reverses experimental pulmonary arterial hypertension in miceHui Li, Xinyu Li, Yu Hao, et al.
Molecular Therapy. Nucleic Acids|July 7, 2022
Upregulation of miR-520c-3p via hepatitis B virus drives hepatocellular migration and invasion by the PTEN/AKT/NF-κB axisYang Liu, Jingwen Wang, Jianwen Chen, et al.
Plant Communications|May 1, 2026
Decoupling the 'Attract-and-Kill' Strategy: Independent Functions for Zoospore Attraction and ROS-Executed Killing Synergize in Disease-Suppressive IntercroppingYixiang Liu, Jiaqing Wu, Yuxin Yang, et al.
Science Translational Medicine|February 11, 2012
AAV2 gene therapy readministration in three adults with congenital blindnessJean Bennett, Manzar Ashtari, Jennifer Wellman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 3, 2009
Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administrationFrancesca Simonelli, Albert M Maguire, Francesco Testa, et al.
Lancet (London, England)|July 5, 2016
Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trialJean Bennett, Jennifer Wellman, Kathleen A Marshall, et al.
Nature|January 14, 2026
Direct observation of the Migdal effect induced by neutron bombardmentDifan Yi, Qian Liu, Shi Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 2, 2025
Recovery of cone-mediated vision in Lebercilin associated retinal ciliopathy after gene therapy: One-year results of a phase I/II trialTomas S Aleman, Katherine E Uyhazi, Alejandro J Roman, et al.
Pageof 16